SCHEMBL20733701

SCHEMBL20733701

Clc1ccc2nc(OI)sc2c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.53
RAB9A P51151 4/20 0.53
SMN1; SMN2 Q16637 3/20 0.53
KMT2A Q03164 3/20 0.53
MAPT P10636 2/20 0.53
MEN1 O00255 2/20 0.53
KDM4E B2RXH2 1/20 0.53
ALDH1A1 P00352 1/20 0.53
LMNA P02545 1/20 0.53
GAA P10253 1/20 0.53
ALOX12 P18054 1/20 0.53
HTT P42858 1/20 0.53
APP P05067 2/20 0.46
DYRK1A Q13627 1/20 0.46
FSCN1 Q16658 1/20 0.46
PTGS1 P23219 2/20 0.44
PTGS2 P35354 2/20 0.44
CASP3 P42574 1/20 0.43
SENP8 Q96LD8 1/20 0.43
SENP7 Q9BQF6 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13071505 0.84 NPC1 (0.51) NPC1RAB9ASMN1; SMN2KMT2AMAPT
SCHEMBL11205335 0.80 KMT2A (0.59) NPC1RAB9ASMN1; SMN2KMT2AMAPT
SCHEMBL11117595 0.79 PTGS1 (0.47) NPC1RAB9ASMN1; SMN2KMT2AMAPT
SCHEMBL13588690 0.78 SMN1; SMN2 (0.50) NPC1RAB9ASMN1; SMN2KMT2AMAPT
SCHEMBL334252 0.78 NPC1 (0.61) NPC1RAB9ASMN1; SMN2KMT2AMAPT
SCHEMBL9307123 0.77 NPC1 (0.56) NPC1RAB9ASMN1; SMN2KMT2AMAPT
SCHEMBL8684173 0.76 PPARA (0.45) NPC1RAB9ASMN1; SMN2KMT2AMAPT
SCHEMBL18612365 0.76 AURKB (0.48) NPC1RAB9ASMN1; SMN2KMT2AMAPT
SCHEMBL18554124 0.76 SMN1; SMN2 (0.44) NPC1RAB9ASMN1; SMN2KMT2AMAPT
SCHEMBL8686061 0.76 PPARA (0.45) NPC1RAB9ASMN1; SMN2KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10702507-B2 Endoparasite control agent THE UNIVERSITY OF TOKYO (JP) 2020-07-07 US disclosed
US-20190046511-A1 ENDOPARASITE CONTROL AGENT THE UNIVERSITY OF TOKYO (JP) 2019-02-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190046511-A1 ENDOPARASITE CONTROL AGENT NAAA, CTRL, ENPP1 NPC1 2985/4885RAB9A 722/4885SMN1; SMN2 4395/4885
US-10702507-B2 Endoparasite control agent NAAA, CTRL, ENPP1 NPC1 2985/4885RAB9A 722/4885SMN1; SMN2 4395/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.